Destination XL’s board has refused Zodiac Partners twice, and the second refusal was the more revealing. The board’s chair, Lionel Conacher, called the 84-cent-a-share cash bid “highly conditional, opportunistic and seemingly timed to deliberately exploit a period of market dislocation.” Beneath the adjectives sits a wager: that a big-and-tall retailer’s proprietary fit data is worth a premium, and not a wasting asset the market has already marked down.

The price is the argument. Zodiac’s opening tender valued the whole company near $46 million, a 26 percent premium over a share already down to 65 cents; a later two-cent raise did not move the board. A premium to a marked-down price is still a discount to what the seller thinks it owns. Whether that is generosity or opportunism depends on who is counting.

The board has begun counting. DXL’s FiTMAP scanner records 243 measurements per customer and has scanned more than 63,000 men, under an exclusive big-and-tall license to 2030. On paper, this is the asset every apparel chief now says he wants.

The bull case is not empty. Fit is the one grievance a big-and-tall man cannot take to Amazon, and a scan that turns a guess into a size saves the margin lost to returns.

But a personalization era pays for behavior, the signal that predicts the next purchase. DXL’s purchase history offers that, and it is the same record every chain keeps. Its rare asset is the body scan, which is anatomical. It records an inseam, not an intention.

Fiscal 2025 sales fell 6.9 percent to $435 million, comparable sales declined in every quarter, and the loss reached $35.9 million, including a $20.4 million non-cash tax charge; the company carried no debt and ended the year with $28.8 million in cash. A dataset that has not reversed a single quarter of decline is being valued, rationally enough, as an expense.

The board’s own remedy half-concedes it. Rather than stand on the fit data alone, DXL has agreed to a stock merger with FullBeauty Brands, a plus-size apparel group with roughly $700 million in sales, that would leave DXL’s own holders with 45 percent of the combined company. An asset you must merge with a larger firm to defend is one its owner has quietly repriced.

Zodiac’s case is not frivolous. Its all-cash offer promises value today against a stock swap into a bigger partner, and a business contracting this fast is a poor candidate to ask its owners for patience.

A company learns the worth of its data the week someone offers too little for it.

Shareholders will decide the appraisal, not the adjectives. Proprietary fit data is not gold in a vault; it is ice, and the question is whether DXL can sell it before it melts.